|
1
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tong W, Ye F, He L, Cui L, Cui M, Hu Y, Li
W, Jiang J, Zhang DY and Suo J: Serum biomarker panels for
diagnosis of gastric cancer. Onco Targets Ther. 9:2455–2463.
2016.PubMed/NCBI
|
|
3
|
Liu WL, Liu D, Cheng K, Liu YJ, Xing S,
Chi PD, Liu XH, Xue N, Lai YZ, Guo L and Zhang G: Evaluating the
diagnostic and prognostic value of circulating cathepsin S in
gastric cancer. Oncotarget. 7:28124–28138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huo YR, Huang Y, Liauw W, Zhao J and
Morris DL: Prognostic value of carcinoembryonic antigen (CEA), AFP,
CA19-9 and CA125 for patients with colorectal cancer with
peritoneal carcinomatosis treated by cytoreductive surgery and
intraperitoneal chemotherapy. Anticancer Res. 36:1041–1049.
2016.PubMed/NCBI
|
|
5
|
Benini L, Cavallini G, Zordan D, Rizzotti
P, Rigo L, Brocco G, Perobelli L, Zanchetta M, Pederzoli P and
Scuro LA: A clinical evaluation of monoclonal (CA19-9, CA50,
CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the
diagnosis of pancreatic cancer. Pancreas. 3:61–66. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JH, Jun KH, Jung H, Park IS and Chin
HM: Prognostic value of preoperative serum levels of five tumor
markers (carcinoembryonic antigen, CA19-9, alpha-fetoprotein,
CA72-4, and CA125) in gastric cancer. Hepatogastroenterology.
61:863–869. 2014.PubMed/NCBI
|
|
7
|
Alexandrakis MG, Passam FH, Kyriakou DS,
Christophoridou AV, Perisinakis K, Hatzivasili A, Foudoulakis A and
Castanas E: Serum level of interleukin-16 in multiple myeloma
patients and its relationship to disease activity. Am J Hematol.
75:101–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mathy NL, Scheuer W, Lanzendörfer M,
Honold K, Ambrosius D, Norley S and Kurth R: Interleukin-16
stimulates the expression and production of pro-inflammatory
cytokines by human monocytes. Immunology. 100:63–69. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schneider MR, Hoeflich A, Fischer JR, Wolf
E, Sordat B and Lahm H: Interleukin-6 stimulates clonogenic growth
of primary and metastatic human colon carcinoma cells. Cancer Lett.
151:31–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chung YC and Chang YF: Serum interleukin-6
levels reflect the disease status of colorectal cancer. J Surg
Oncol. 83:222–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kai H, Kitadai Y, Kodama M, Cho S, Kuroda
T, Ito M, Tanaka S, Ohmoto Y and Chayama K: Involvement of
proinflammatory cytokines IL-1beta and IL-6 in progression of human
gastric carcinoma. Anticancer Res. 25:709–713. 2005.PubMed/NCBI
|
|
12
|
Atanackovic D, Hildebrandt Y, Templin J,
Cao Y, Keller C, Panse J, Meyer S, Reinhard H, Bartels K, Lajmi N,
et al: Role of interleukin 16 in multiple myeloma. J Natl Cancer
Inst. 104:1005–1020. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Villano V, Di Stadio CS, Federico A,
Altieri F, Miselli G, De Palma M, Rippa E and Arcari P: Gastrokine
1 mRNA in human sera is not informative biomarker for gastric
cancer. J Negat Results Biomed. 15:142016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cicchillitti L, Corrado G, Carosi M,
Dabrowska ME, Loria R, Falcioni R, Cutillo G, Piaggio G and Vizza
E: Prognostic role of NF-YA splicing isoforms and Lamin A status in
low grade endometrial cancer. Oncotarget. 8:7935–7945.
2017.PubMed/NCBI
|
|
16
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krzanowski WJ and Hand DJ: ROC curves for
continuous dataChapman & Hall/CRC monographs on statistics
& applied probability. 2009, Chapman and Hall/CRC; View Article : Google Scholar
|
|
18
|
Jia S and Cai J: Update on biomarkers in
development of anti-angiogenic drugs in gastric cancer. Anticancer
Res. 36:1111–1118. 2016.PubMed/NCBI
|
|
19
|
Matsueda S and Graham DY: Immunotherapy in
gastric cancer. World J Gastroenterol. 20:1657–1666. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guadagni F, Roselli M, Cosimelli M,
Ferroni P, Spila A, Cavaliere F, Casaldi V, Wappner G, Abbolito MR,
Greiner JW, et al: CA 72-4 serum marker-a new tool in the
management of carcinoma patients. Cancer Invest. 13:227–238. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carpelan-Holmström M, Louhimo J, Stenman
UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA 72-4 improve the
diagnostic accuracy in gastrointestinal cancers. Anticancer Res.
22:2311–2316. 2002.PubMed/NCBI
|
|
23
|
Liu X, Qiu H, Liu J, Chen S, Xu D, Li W,
Zhan Y, Li Y, Chen Y, Zhou Z and Sun X: Combined preoperative
concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in
patients with gastric cancer after curative resection. Oncotarget.
7:35446–35453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Comperat E, Roupret M, Drouin SJ, et al:
Tissue expression of IL16 in prostate cancer and its association
with recurrence after radical prostatectomy. Prostate.
70:1622–1627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yellapa A, Bitterman P, Sharma S, et al:
Interleukin 16 expression changes in association with ovarian
malignant transformation. Am J Obstet Gynecol. 210:272 e1–10. 2014.
View Article : Google Scholar
|
|
26
|
Hussain SP and Harris CC: Inflammation and
cancer: An ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin X, Peng Q, Lao X, et al: The
association of interleukin-16 gene polymorphisms with IL-16 serum
levels and risk of nasopharyngeal carcinoma in a Chinese
population. Tumour Biol. 35:1917–1924. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T and Wang H: Variants of
interleukin-16 associated with gastric cancer risk. Asian Pac J
Cancer Prev. 14:5269–5273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yellapa A, Bahr JM, Bitterman P,
Abramowicz JS, Edassery SL, Penumatsa K, Basu S, Rotmensch J and
Barua A: Association of interleukin 16 with the development of
ovarian tumor and tumor-associated neoangiogenesis in laying hen
model of spontaneous ovarian cancer. Int J Gynecol Cancer.
22:199–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kang WM, Meng QB, Yu JC, Ma ZQ and Li ZT:
Factors associated with early recurrence after curative surgery for
gastric cancer. World J Gastroenterol. 21:5934–5940. 2015.
View Article : Google Scholar : PubMed/NCBI
|
